纳夫托基诺支架衍生化合物的对头部和部状细胞癌的影响,基于网络药理学和分子对接

Yiheng Liao1, Lin Qiu1, Anqi Tao1

  • 1Central Laboratory, Peking University School and Hospital of Stomatology and National Center for Stomatology and National Clinical Research Center for Oral Diseases and National Engineering Research Center of Oral Biomaterials and Digital Medical Devices Beijing 100081, China.

概括

纳夫托金化合物显示为新型化疗剂的承诺,用于头部和部状细胞癌 (HNSCC). 网络药理学和分子对接确定了关键目标,表明了新的HNSCC治疗的潜力.